肿瘤整形缩乳术后放疗启动时间与并发症的关联
该单中心回顾性分析纳入1997至2015年接受肿瘤整形缩乳(OCR)并术后辅助放疗的118例患者,排除接受辅助化疗或非手术原因延误放疗者,比较有无手术并发症患者至放疗时间的差异。结论认为OCR术后并发症与辅助放疗启动延迟相关,无论并发症是否需要再次手术。
要点
- OCR术后并发症组放疗启动中位时间为74天,无并发症组为54天(P < 0.001)。
- 全队列5%(6/118)因并发症需二次手术,但需再手术者与未再手术者放疗时间无差异(73天 vs 74天,P = 0.692)。
- 规划OCR联合放疗时应尽量通过患者选择与手术技术减少并发症。
核心结论
- OCR术后并发症与辅助放疗启动时间延长相关,且与并发症是否需再次手术无关。
- 规划OCR与放疗联合方案时应重视并发症防控以减少放疗延迟。
研究设计与样本
- 单中心回顾性分析,纳入1997至2015年接受OCR并术后辅助放疗的患者共118例。
- 排除接受辅助化疗或因非手术原因延误放疗者,比较有无手术并发症患者的至放疗时间。
主要发现
- 有并发症者放疗启动中位时间74天,无并发症者54天,差异有统计学意义(P < 0.001)。
- 全队列5%(6/118)因并发症需二次手术,包括血肿、感染、血清肿、开放伤口、伤口哆开和乳头坏死。
- 需再手术的并发症患者放疗中位时间73天,未再手术者为74天,差异无统计学意义(P = 0.692)。
关键数值与推荐
- 有无并发症两组放疗启动中位时间:74天 vs 54天,P < 0.001。
- 因并发症需二次手术者占5%(6/118)。
- 需再手术者与未再手术者放疗中位时间:73天 vs 74天,P = 0.692。
临床怎么用
- 术前应向患者说明OCR术后并发症可能延长至放疗时间。
- 通过严格患者选择与精细手术技术尽量减少并发症,保障放疗及时启动。
局限性
- 为单中心回顾性研究,样本量118例。
- 排除了接受辅助化疗及非手术原因延误放疗者,结论适用范围受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Partial breast reconstruction with reduction mammaplasty is an accepted option for women with breast cancer who wish to receive breast conserving therapy. With additional surgery and potential postoperative complications, the impact this approach has on the timely initiation of adjuvant radiation therapy has been raised as a concern. The purpose of this study was to determine if any postoperative complications after oncoplastic reduction (OCR) are associated with a delay in time to radiation. METHODS: All patients undergoing OCR with postoperative adjuvant radiation at a single institution between 1997 and 2015 were included in the analysis. Women who received adjuvant chemotherapy or experienced delays in radiation therapy due to nonsurgical reasons were excluded from our analysis. Comparisons were made between the time to radiation for patients with surgical complications and those without. RESULTS: One hundred eighteen patients were included. Twenty-six (22.0%) experienced a surgical complication. Complications included cellulitis, delayed healing, seroma, wound breakdown, and wound dehiscence. Postoperative complications resulted in a significantly different median time interval for initiation of radiation (74 days vs 54 days, P < 0.001) compared to those without a complication. Among the entire cohort, 5% of patients required a second operative procedure due to complications. (n = 6/118 patients) including hematoma, infection, seroma, open wounds, wound dehiscence, and nipple necrosis. There was no difference in median time to radiation therapy in those with complications who returned to the operating room (73 days) compared to those who did not (74 days, P = 0.692). CONCLUSION: Postoperative complications following OCR procedures were associated with an increased time to initiation of adjuvant radiation therapy regardless of whether or not the complication required reoperation. This needs to be taken into consideration when planning these combined procedures with every attempt made to minimize complications through patient selection and surgical technique.
引用
- Kapadia SM, Reitz A, Hart A, et al. Time to Radiation After Oncoplastic Reduction. Ann Plast Surg. 2019. PMID: 30211738. doi:10.1097/SAP.0000000000001598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。